Engineered for targeted relief, immediate temperature regulation, and advanced wound management. Discover our premier clinical-grade solutions.
The global analgesic topical market is shifting rapidly from conventional ointments and rubs to advanced transdermal patches and hydrogels. This transition is driven by the clinical need for targeted drug delivery, localized therapeutic action, and minimized systemic side effects.
Modern formulations leverage hydrogel and polymer matrices to bypass the digestive tract, ensuring active ingredients (such as Lidocaine, Capsaicin, or Methyl Salicylate) penetrate the stratum corneum at a controlled rate directly to the affected nociceptors.
Standard ointments require frequent reapplication. Modern transdermal delivery systems utilize multi-laminate patch designs that maintain stable drug concentrations for 8 to 24 hours, enhancing patient compliance.
Hypoallergenic adhesives, particularly silicone-based and hydrocolloid materials, have replaced aggressive rubber-based adhesives. This ensures pain-free removal, crucial for geriatric and pediatric demographics.
Market Intelligence Report: The compound annual growth rate (CAGR) for topical pain patches is projected to expand by 6.8% over the next decade. B2B buyers are increasingly prioritizing suppliers with robust regulatory portfolios, ISO cleanrooms, and flexible contract manufacturing capabilities (OEM/ODM).
Hubei ProMix Medical Co., Ltd. is a modern high-tech enterprise integrating research and development, manufacturing, sales, and service of advanced medical materials. The company specializes in functional wound dressings, medical plasters, and personal healthcare products, providing comprehensive solutions for global healthcare needs.
Founded in 2002 and located in Huazhong International Industrial Park, ProMix Medical has grown into a diversified industrial group with more than ten wholly owned subsidiaries, covering sectors such as medical technology, medical devices, biopharmaceuticals, and research institutes. Backed by over 20 years of industry experience, the company has established a strong foundation in innovation and product development.
ProMix Medical holds more than 100 intellectual property rights, including invention patents and utility model patents. The company has passed multiple international quality management system certifications such as ISO 13485, ISO 9001, ISO 14001, and ISO 45001. Its products are certified by global regulatory authorities including CE, FDA, TGA, and HSA, and are exported to over 170 countries and regions worldwide. In the domestic market, the company holds nearly 100 NMPA certifications and serves more than 20,000 medical institutions.
Driven by innovation and quality excellence, ProMix Medical has received wide recognition from government authorities and industry organizations. It has been honored with titles such as "High-Tech Enterprise," "Intellectual Property Advantage Enterprise," "Gazelle Enterprise," and "Specialized and Sophisticated 'Little Giant' Enterprise." The company also plays an active role in industry development as a key member and leader in multiple research and innovation alliances related to traditional and modern medical therapies.
Our facility features class 100,000 cleanrooms and advanced automation lines, ensuring batch-to-batch consistency and strict compliance with medical device regulations.
Raw Materials Selection
Precision Slitting
Rotary Die-cutting
Cutting Pieces
Print Marking
Packing (Primary)
Secondary Die-cutting
Cutting Pieces
Secondary Packing
Final Carton Packing
To maintain precision, we employ computer-controlled circular die-cutters, high-speed slitters, and laminating technology that handles multi-layer transdermal configurations without cross-contamination.
Die Cutting Machine
Slitting Machine
Circular Die Cutter
Laminating Machine
Cutting Machine
Rewinder Unit A
In-line Flexo Printer
Rewinder Unit B
High-Speed Rotary Die Cutter
Automatic Film Sealer
Intelligent Automatic Packaging Line
By integrating advanced scientific research with traditional healing concepts, ProMix Medical develops safe, effective, and high-quality healthcare products.
Building a professional platform for a harmonious and healthy industry ecosystem.
A leading Chinese expert in medical plasters and wound dressing solutions.
Focusing on green technology and caring for life and health.
To become a preferred innovative brand in the global health industry driven by science and technology.
People-oriented, co-creation, and shared success.
Serving society and improving human health worldwide.
With a focus on purity, innovation, and technological excellence, ProMix continuously delivers products that meet evolving global healthcare standards. The brand reflects not only technological advancement but also a deep commitment to improving quality of life, representing a harmonious blend of tradition, innovation, and human-centered care.
Sourcing pain relief ointments and transdermal patches requires navigating logistics, raw material consistency, and regulatory pathways. Here is how Hubei ProMix Medical supports your supply chain resilience.
Located in Central China, our proximity to petrochemical processing bases and raw agricultural inputs (herbal extracts, polymers, non-woven backings) minimizes domestic transport delays. We run fully integrated lines from raw compound formulation to primary unit packaging, insulating clients from external vendor delays.
Our high-throughput machinery runs 24/7. By distributing overhead costs across hundreds of millions of units annually, we provide competitive unit costs while maintaining cleanroom standards. This allows our global partners to maintain healthy retail and distribution margins.
Whether you need specific dimensions, hydrocolloid thicknesses, custom active ingredient release curves, or localized consumer packaging, our in-house engineering and R&D teams will guide you from initial prototyping to pilot batches and full-scale validation.
We welcome third-party inspections and customer audits. Our Quality Management System (QMS) is certified by international registrars, offering comprehensive trace documentation, micro-biological analysis, and bioburden tests for every production run.
Navigating regional health authority certifications is critical. We provide complete dossier support (including CTD format dossiers) to expedite product approvals.
| Target Region | Key Regulatory Certification | Compliance & Packaging Requirements | ProMix Support Provided |
|---|---|---|---|
| United States | FDA OTC Drug / Class I/II Device | National Drug Code (NDC) registration, drug facts label alignment, child-resistant packaging. | FDA registered facility, master files access, labeling review. |
| European Union | CE Mark (MDR 2017/745) | Technical files compliance, European Representative (EC Rep) integration, multi-language packaging. | ISO 13485 compliance, complete technical dossiers, CE certification. |
| Australia | TGA Registration | Sponsor declarations, GMP clearance, ARTG listing validation. | TGA audit-ready documentation and quality certificates. |
| Southeast Asia | HSA / Local NMPA equivalent | ASEAN Harmonized Cosmetic/Medical Device Dossier formats. | Bilingual clinical trial data, stability test reports. |
Browse our range of targeted medical devices, surgical tapes, and specialized veterinary products, built on identical quality standards.
Get quick answers regarding product specifications, formulations, international logistics, and private label setups.
We can formulate patches with standard OTC active ingredients such as Methyl Salicylate, Menthol, Camphor, Capsaicin, Lidocaine, and custom herbal extracts. Our R&D team works with you to balance drug loading, skin permeation, and adhesive stability.
Yes. Hubei ProMix Medical holds ISO 13485, ISO 9001, ISO 14001, and ISO 45001 certifications. Our products hold CE, FDA, TGA, and HSA clearances, making them ready for distribution in major regulated markets.
For OEM orders, the average lead time is 30 to 45 days. This includes packaging customization, design proof sign-offs, and micro-biological validation. Repeat orders with stabilized specifications typically ship within 20 to 30 days.
We source medical-grade, hypoallergenic acrylic hydrogels and silicone adhesives. Every formula undergoes rigorous biocompatibility testing, including skin irritation, sensitization, and cytotoxicity evaluations, to minimize adverse skin reactions.
Yes, our regulatory department prepares and provides complete technical dossiers (such as CE technical files or FDA NDC registration paperwork) to support our clients' local distribution listings.
ProMix Medical